- $147.23bn
- $206.70bn
- $58.50bn
- 67
- 65
- 49
- 63
Pfizer Inc - Lipitor Provides Greater Benefit Compared to simvastatin in Patient
AnnouncementPfizer Inc - New Lipitor Data Analyses from Landmark Ideal and SPARCL Trials to
AnnouncementPfizer Inc - Pfizer joint with Monogram.
AnnouncementPfizer Inc - DOJ Announcement
AnnouncementPfizer Inc - Pfizer Invites Public to View and Listen to Webcast of Pfizer Parti
AnnouncementPfizer Inc - FDA Advisory Committee Recommends Approval Of Exubera
AnnouncementPfizer Inc - FDA Advisory Committee Recommends Approval Of Exubera
AnnouncementPfizer Inc Pfizer And Medivation Announce Results
AnnouncementPfizer Inc - Pfizer to Share New Data and Portfolio Update on Infectious Disease
AnnouncementPfizer Inc - Pfizer Obtains Clearance from Federal Cartel Office of Germany for
AnnouncementPfizer Inc - 1st Quarter Results
AnnouncementPfizer Inc - Post-Stroke Patients Treated with Lipitor Demonstrated Significant
AnnouncementPfizer Inc - Webcast
AnnouncementPfizer Inc - Pfizer Clears U.S. Antitrust Review for Acquisition of All Outstand
AnnouncementPfizer Inc - Acquisition(s)
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc - Pfizer Says Research and Development Head John LaMattina Will Retir
AnnouncementPfizer Inc - Pfizer Inc. and the University of Pennsylvania Announce $15 Million
AnnouncementPfizer Inc - Pfizer Inc Announces Completion of the Tender Offer Relating to Out
Announcement